Indatuximab ravtansine
Indatuximab ravtansine Uses, Dosage, Side Effects, Food Interaction and all others data.
Indatuximab ravtansine is under investigation in clinical trial NCT01001442 (Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma).
| Trade Name | Indatuximab ravtansine |
| Generic | Indatuximab ravtansine |
| Indatuximab ravtansine Other Names | Indatuximab ravtansine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Indatuximab ravtansine
